What is the recovery time after stem cell therapy for Premature Ovarian Insufficiency?
Recovery and risk depend on whether administration is intravenous, ovarian or surgical and whether sedation is used, so a universal outpatient or fertility timeline is unsafe. Trial documents should describe anaesthesia, bleeding, infection, ovarian injury, adverse-event and emergency arrangements and follow-up. A pregnancy timeline cannot be promised from an experimental procedure.
What the evidence shows for Premature Ovarian Insufficiency
POI cell-therapy evidence is early and heterogeneous. Menstruation, hormone levels, ultrasound follicles, oocyte retrieval, pregnancy and live birth are different outcomes and must not be treated as interchangeable. Small uncontrolled series cannot establish that an intervention restored ovarian function or caused a pregnancy. No pooled response rate is published here because product, route, patient selection and endpoints differ too widely. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Am I a candidate? → · Premature Ovarian Insufficiency: full overview → · Premature Ovarian Insufficiency cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Premature Ovarian Insufficiency: cell-therapy evidence and registered trials
- How much does stem cell therapy for Premature Ovarian Insufficiency cost? (2026)
- Premature Ovarian Insufficiency stem cell therapy — your questions answered (2026)
- Premature Ovarian Insufficiency: cell-therapy evidence by therapy class
- MSC vs PRP for Premature Ovarian Insufficiency: what the registries show